ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "methotrexate (MTX) and clinical trials"

  • Abstract Number: 524 • 2019 ACR/ARP Annual Meeting

    A Comparison of Upadacitinib Plus Methotrexate and Upadacitinib Plus Other CsDMARDs in Patients with Rheumatoid Arthritis: An Analysis of Two Phase 3 Studies

    Joel Kremer1, Filip Van den Bosch 2, Andrea Rubbert-Roth 3, Sebastiao Radominski 4, Gerd Burmester 5, Heidi Camp 6, Sebastian Meerwein 7, Mark Howard 8, Yanna Song 9, Sheng Zhong 10 and Bernard Combe 11, 1Albany Medical College, Albany, NY, 2Ghent University Hospital, Ghent, Belgium, 3Kantonsspital St. Gallen, St Gallen, Switzerland, 4Universidade Federal do Paraná, Curitiba, Brazil, 5Charité—University Medicine Berlin, Berlin, Germany, 6AbbVie Inc., North Chicago, IL, 7AbbVie GmbH Co. KG, Ludwigshafen, Germany, Wiesbaden, Germany, 8AbbVie Inc., North Chicago, 9AbbVie Inc., North Chicago, IL, USA, North Chicago, 10AbbVie Inc., North Chicago, IL, USA, North Chicago, IL, 11CHU Montpellier, Montpellier University, Montpellier, France

    Background/Purpose: Upadacitinib (UPA), a selective JAK1 inhibitor, has shown efficacy in patients with rheumatoid arthritis (RA) when combined with methotrexate (MTX) or other conventional synthetic…
  • Abstract Number: 1438 • 2019 ACR/ARP Annual Meeting

    Discontinuation of Concomitant Methotrexate in Japanese Patients with Rheumatoid Arthritis Treated with Tocilizumab: An Interventional Study

    Toshihisa Kojima1, Shuji Asai 1, Masahiro Hanabayashi 2, Masatoshi Hayashi 3, Nobunori Takahashi 1, Yachiyo Kuwatsuka 4, Masahiko Ando 4 and Naoki Ishiguro 1, 1Department of Orthopedic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan, 2Ichinomiya Municipal Hospital, Ichinomiya, Japan, 3Hayashi Orthopedic Clinic, Nagano, Japan, 4Nagoya University Hospital, Nagoya, Japan

    Background/Purpose: Biological DMARD (bDMARD) concomitant with methotrexate (MTX) has made great progress in the treatment of rheumatoid arthritis (RA) in these decades. There are various…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.